First patient enrolled in GOG-3132/BEHOLD-Ovarian01 phase 3 study evaluating Mocertatug Rezetecan, a novel B7-H4–targeted ADC, in platinum-resistant ovarian cancer
Business Announcement
Business Announcement
Latest News Releases
Updates every hour. Last Updated: 31-Oct-2026 02:15 ET (31-Oct-2026 06:15 GMT/UTC)
Business Announcement
Monica L. Baskin, Ph.D., named director of VCU Massey Comprehensive Cancer Center
Business Announcement
University of Tennessee names Governor’s Chair for Nuclear Medicine
Business Announcement
Internationally recognized expert leads University of Maryland School of Medicine program in sickle cell disease
Business Announcement
Houston Methodist researchers develop biodegradable implant that delivers targeted cancer immunotherapy while protecting healthy tissue
Peer-Reviewed Publication
Alzheimer’s biomarker P-tau 217 is weak in preclinical studies
Peer-Reviewed Publication
Dual PI3K/HDAC inhibitor CUDC-907 enhances temozolomide response in glioblastoma
Peer-Reviewed Publication
Study reveals why DNA damage from smoking, UV rays and other factors may cause cancer in some people but not others
Peer-Reviewed Publication
Bugs as drugs: Engineered gut bacteria show promise against pancreatic cancer
Peer-Reviewed Publication
Genetic makeup affects whether patients experience benefits or side effects of immune cell therapy for cancer
Peer-Reviewed Publication